Antibiotic-Resistant Gonorrhea Is A Looming Threat

The Centers for Disease Control and Prevention reported Thursday that Neisseria gonorrhoeae ― that is, the bacteria that causes gonorrhea ― could be developing resistance to our last-line antibiotics that treat it. The CDC’s current gold standard treatment for gonorrhea is a combination of two drugs, azithromycin and ceftriaxone, to ensure that if one drug doesn’t kill the bacteria, the other will finish the job. Now, a rise in antibiotic resistance among these two bacteria since 2014 has experts worried. “History has taught us that this bacteria has the ability to develop resistance to antibiotics, and sometimes it can do it quite quickly,” Dr. Robert Kirkcaldy, a medical epidemiologist in the CDC’s STD prevention division told The Huffington Post. “Our ability to cure people of gonorrhea is going to fade unless we take steps now address growing antibiotic resistance.” That said, the United States has not encountered any cases of gonorrhea that are untreatable so far, and despite rising antibiotic resistance, overall resistance rates for the combination treatments are relatively low: just 2.5 percent for azithromycin and 0.8 percent for ceftriaxone. As it stands, gonorrhea is the second-most common sexually transmitted infection in the United States, with more than 350,000 reported cases of the infection in 2014. And while gonorrhea has traditionally has been easy to cure, if left untreated, it can cause severe rep...
Source: Science - The Huffington Post - Category: Science Source Type: news

Related Links:

Conclusions:Results provide preliminary evidence that an intervention to reduce supine sleep in late pregnancy may provide maternal and fetal health benefits, with minimal effect on maternal perception of sleep quality and objectively estimated sleep time. Further research to explore relationships between objectively determined maternal sleep position, maternal respiratory indices, and fetal well-being is warranted.Citation:Warland J, Dorrian J, Kember AJ, Phillips C, Borazjani A, Morrison JL, O'Brien LM. Modifying maternal sleep position in late pregnancy through positional therapy: a feasibility study.J Clin Sleep Med. 2...
Source: Journal of Clinical Sleep Medicine : JCSM - Category: Sleep Medicine Source Type: research
Democratic Republic of Congo has started using the experimental mAb114 Ebola treatment to counter the latest flare-up of the virus, health officials said on Tuesday, the first time it has been deployed against an active outbreak.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Following a two-day mission in the Democratic Republic of Congo, the Head of the World Health Organization (WHO) on Tuesday repeated his call for warring parties in conflict-riven North Kivu to stop fighting, and allow health teams access to areas affected by the recent Ebola outbreak in the region.
Source: UN News Centre - Health, Poverty, Food Security - Category: International Medicine & Public Health Source Type: news
Officials are hoping a new treatment can help patients already infected with the deadly virus, as they continue a vaccination campaign to prevent it.
Source: CBC | Health - Category: Consumer Health News Tags: News/Health Source Type: news
CONCLUSION: Peer mentoring programmes can play an important role in reducing vertical HIV transmission in resource-limited, rural settings by providing participants with education, psychosocial support, and a continuum of care. PMID: 30102134 [PubMed - as supplied by publisher]
Source: Paediatrics and international child health - Category: Pediatrics Tags: Paediatr Int Child Health Source Type: research
The Dept. of Health and Human Services’ Biomedical Advanced Research and Development Authority and Johnson &Johnson‘s (NYSE:JNJ) Janssen R&D are launching a new crowdsourced tech development challenge looking to support innovative respiratory protection devices, according to a recently listed government posting. The new contest, dubbed the QuickFire Challenge, will look to award up to $100,000 to developers of “reimagined, transformative respiratory protection” devices, according to the release. Both J&J’s Janssen and BARDA will collaborate on the challenge, alongside J&J’s JLABS inc...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Research & Development Respiratory Dept. of Health & Human Services (HHS) johnsonandjohnson Source Type: news
This article aims to prevent the possible recurrence of the Middle East Respiratory Syndrome (MERS) by understanding the status of South Korea's public healthcare system through a literature review. In addition, it presents measures to reinforce the public health system by analyzing the roles and limitations of the health authority, which plays a key role in preventing the spread of this infectious disease, through their response to the recent MERS outbreak in the country. Based on the analysis, the results showed the following implications: (1) Community health centers need to expand and reinforce their functions. It is i...
Source: International Journal of E-Health and Medical Communications - Category: Information Technology Authors: Tags: Health Information Systems Medicine & Healthcare Source Type: research
Conclusions Our findings suggest that the likelihood of receiving neuraxial analgesia is only marginally increased for morbidly obese women compared to women with normal body mass index.
Source: Anesthesiology - Category: Anesthesiology Source Type: research
Officials are again warning residents of a northeast Arkansas town of a possible hepatitis A exposure after an employee at a barbecue restaurant tested positive for the liver disease.
Source: Arkansas Business - Health Care - Category: American Health Source Type: news
Condition:   Periodontitis Interventions:   Other: Lactose tab;   Drug: Azithromycin Sponsor:   Universidad Nacional Andres Bello Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Antimicrobial Resistance | Azithromycin | Budgets | Ceftriaxone | Centers for Disease Control and Prevention (CDC) | Epidemiology | Eyes | Government | Health | Health Management | Hospitals | Infectious Diseases | Infertility | Intensive Care | International Medicine & Public Health | National Institutes of Health (NIH) | Outbreaks | Podcasts | Pregnancy | Reproduction Medicine | Rocephin | Science | STDs | Superbugs | Washington University | Websites | WHO | Women | Zithromax